Innovative Regional Therapy for Head and Neck Cancer
- 1 November 1982
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 108 (11) , 703-708
- https://doi.org/10.1001/archotol.1982.00790590025008
Abstract
• A totally implantable infusion pump (Infusaid) has been developed to achieve continuous drug delivery for long periods of time. The recent availability of a dualcatheter totally implantable infusion pump permits the infusion of both external carotid arteries simultaneously. This has obvious advantages for the treatment of extensive tumors of the head and neck that extend across the midline. Likewise, for the first time, unilateral local-regional disease that extends inferiorly beyond the nutrient field of the external carotid artery may be treated with intra-arterial infusion chemotherapy without the need to infuse the common carotid or innominate arteries. Unilateral infusion of the entire head and neck is accomplished by using the dual-catheter pump to infuse both the thyrocervical trunk and the external carotid artery. (Arch Otolaryngol 1982;108:703-708)Keywords
This publication has 4 references indexed in Scilit:
- The chemotherapy of head and neck cancerAnti-Cancer Drugs, 1999
- Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II in an effective outpatient scheduleCancer, 1979
- Results in 169 patients with cancer of the head and neck treated by intra-arterial infusion therapyThe American Journal of Surgery, 1972
- Factors influencing the success of arterial infusion chemotherapy for cancer of the head and neckThe American Journal of Surgery, 1972